ES2347774T5 - Composición para la estimulación del crecimiento óseo y el mantenimiento de la salud ósea - Google Patents

Composición para la estimulación del crecimiento óseo y el mantenimiento de la salud ósea Download PDF

Info

Publication number
ES2347774T5
ES2347774T5 ES02805314.8T ES02805314T ES2347774T5 ES 2347774 T5 ES2347774 T5 ES 2347774T5 ES 02805314 T ES02805314 T ES 02805314T ES 2347774 T5 ES2347774 T5 ES 2347774T5
Authority
ES
Spain
Prior art keywords
bone
composition
maintenance
health
growth stimulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02805314.8T
Other languages
English (en)
Other versions
ES2347774T3 (es
Inventor
Elizabeth Offord-Cavin
Ermanno Federici
Bernard Lemaure
Didier Courtois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8181405&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2347774(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of ES2347774T3 publication Critical patent/ES2347774T3/es
Application granted granted Critical
Publication of ES2347774T5 publication Critical patent/ES2347774T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/882—Acoraceae (Calamus family), e.g. sweetflag or Acorus calamus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/89—Cyperaceae (Sedge family)
    • A61K36/8905—Cyperus (flatsedge)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7

Claims (1)

  1. imagen1
ES02805314.8T 2001-12-11 2002-12-10 Composición para la estimulación del crecimiento óseo y el mantenimiento de la salud ósea Expired - Lifetime ES2347774T5 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01204838A EP1325681A1 (en) 2001-12-11 2001-12-11 Composition for promotion of bone growth and maintenance of bone health
EP01204838 2001-12-11
PCT/EP2002/014120 WO2003053167A1 (en) 2001-12-11 2002-12-10 Composition for promotion of bone growth and maintenance of bone health

Publications (2)

Publication Number Publication Date
ES2347774T3 ES2347774T3 (es) 2010-11-04
ES2347774T5 true ES2347774T5 (es) 2015-01-12

Family

ID=8181405

Family Applications (4)

Application Number Title Priority Date Filing Date
ES02805314.8T Expired - Lifetime ES2347774T5 (es) 2001-12-11 2002-12-10 Composición para la estimulación del crecimiento óseo y el mantenimiento de la salud ósea
ES09172445T Expired - Lifetime ES2387634T3 (es) 2001-12-11 2002-12-10 Composición para la estimulación del crecimiento óseo y el mantenimiento de la salud ósea
ES10176057T Expired - Lifetime ES2387877T3 (es) 2001-12-11 2002-12-10 Composición para la estimulación del crecimiento óseo y el mantenimiento de la salud ósea
ES10176060T Expired - Lifetime ES2387876T3 (es) 2001-12-11 2002-12-10 Composición para la estimulación del crecimiento óseo y el mantenimiento de la salud ósea, que comprende extractos de Mentha

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES09172445T Expired - Lifetime ES2387634T3 (es) 2001-12-11 2002-12-10 Composición para la estimulación del crecimiento óseo y el mantenimiento de la salud ósea
ES10176057T Expired - Lifetime ES2387877T3 (es) 2001-12-11 2002-12-10 Composición para la estimulación del crecimiento óseo y el mantenimiento de la salud ósea
ES10176060T Expired - Lifetime ES2387876T3 (es) 2001-12-11 2002-12-10 Composición para la estimulación del crecimiento óseo y el mantenimiento de la salud ósea, que comprende extractos de Mentha

Country Status (23)

Country Link
US (2) US20050079232A1 (es)
EP (6) EP1325681A1 (es)
JP (3) JP4653951B2 (es)
KR (1) KR20040083466A (es)
CN (1) CN100521972C (es)
AT (1) ATE472943T1 (es)
AU (3) AU2002366734B2 (es)
BR (1) BR0214838A (es)
CA (1) CA2469551C (es)
CO (1) CO5590866A2 (es)
DE (1) DE60236961D1 (es)
DK (4) DK2135517T3 (es)
ES (4) ES2347774T5 (es)
HK (1) HK1076009A1 (es)
IL (2) IL161659A0 (es)
MX (1) MXPA04005583A (es)
NO (1) NO327135B1 (es)
PL (1) PL369768A1 (es)
PT (4) PT2263480E (es)
RU (1) RU2314717C2 (es)
UA (1) UA84123C2 (es)
WO (1) WO2003053167A1 (es)
ZA (1) ZA200405454B (es)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1325681A1 (en) * 2001-12-11 2003-07-09 Société des Produits Nestlé S.A. Composition for promotion of bone growth and maintenance of bone health
CA2500527A1 (en) * 2002-10-01 2004-04-15 Takara Bio Inc. Remedies
US7435431B2 (en) * 2004-07-28 2008-10-14 Abbott Laboratories Method for controlling body weight in estrogen-insufficient women
US20060040001A1 (en) * 2004-07-28 2006-02-23 Johnson Catherine D Nutritional compositions and methods for treating or preventing osteoporosis
US7601370B2 (en) * 2004-07-28 2009-10-13 Abbott Laboratories Method for controlling body weight in estrogen-insufficient women
JP4738007B2 (ja) * 2005-02-04 2011-08-03 久光製薬株式会社 骨粗鬆症治療用外用剤
US8216801B2 (en) * 2005-02-25 2012-07-10 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), The Volcani Center Methods for treating inflammatory disorders
WO2008004118A2 (en) * 2006-07-06 2008-01-10 Avestha Gengraine Technologies Pvt. Ltd. Carthamus tinctoris plant extracts for treating osteoporosis and the extraction process thereof
EP2081570A2 (en) * 2006-10-24 2009-07-29 David W. Krempin Anti-resorptive and bone building dietary supplements and methods of use
US20080200425A1 (en) * 2007-02-16 2008-08-21 Kurtz Seymour J Methods and compositions for regulating bone mineral density
KR100902947B1 (ko) * 2007-03-07 2009-06-15 주식회사 피앤비 바실러스 서브틸리스 모리 배양물을 함유하는 성장촉진용조성물
WO2009052182A1 (en) 2007-10-15 2009-04-23 Jbs United, Inc. Method for increasing performance of offspring
MX2010009314A (es) * 2008-02-25 2010-09-24 Nestec Sa Polifenoles para el tratamiento de padecimientos de cartilago.
JP2009269834A (ja) * 2008-05-01 2009-11-19 Dhc Co 骨吸収抑制剤並びに骨吸収抑制用飲食品及び医薬部外品
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US20100041768A1 (en) * 2008-08-18 2010-02-18 National Yang-Ming University Composition and method of adipose cell differentiation inhibition
KR101096574B1 (ko) * 2008-12-12 2011-12-20 에이치 엘 지노믹스(주) 유럽종 포도의 씨 추출물을 함유하는 골다공증 예방 또는 치료용 약학 조성물
KR101099021B1 (ko) * 2009-04-24 2011-12-28 에이치 엘 지노믹스(주) 유럽종 포도의 씨 추출물을 함유하는 골관절염 예방 또는 치료용 약학 조성물
US7897184B1 (en) * 2009-08-13 2011-03-01 Access Business Group International Llc Topical composition with skin lightening effect
RU2509569C2 (ru) * 2011-07-05 2014-03-20 Общество С Ограниченной Ответственностью "Парафарм" Композиция для лечения и предупреждения остеоартрита и остеоартроза суставов
DK3009010T3 (da) 2011-12-19 2020-05-11 Purecircle Sdn Bhd Fremgangsmåder til oprensning af steviolglycosider
KR101318160B1 (ko) * 2011-12-20 2013-10-16 주식회사 진생사이언스 골형성을 촉진하는 효능을 가지는 ｄｓｘ 추출물을 유효성분으로 하는 약학 조성물
DE102011122466A1 (de) * 2011-12-24 2013-06-27 Westfalia-Automotive Gmbh Hohlträger für ein Anhängesystem eines Kraftfahrzeugs
KR20140057709A (ko) * 2012-10-31 2014-05-14 (주)메디언스 키성장 및 골 강화용 조성물
CN105407738A (zh) 2012-12-19 2016-03-16 可口可乐公司 用于提高莱鲍迪苷x溶解度的组合物和方法
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
JP2016512021A (ja) 2013-03-08 2016-04-25 アクシオム フーズ インコーポレイテッド 米タンパク質補助食品
US20140272068A1 (en) 2013-03-14 2014-09-18 Indra Prakash Beverages containing rare sugars
WO2014172055A2 (en) 2013-03-15 2014-10-23 The Coca-Cola Company Novel glucosyl steviol glycosides, their compositions and their purification
EP2970354B1 (en) 2013-03-15 2018-05-30 The Coca-Cola Company Steviol glycosides and their compositions
US10905146B2 (en) 2013-07-12 2021-02-02 The Coca-Cola Company Compositions for improving rebaudioside M solubility
KR101487761B1 (ko) * 2013-11-05 2015-01-29 한국생명공학연구원 아르테미시닌을 유효성분으로 포함하는 골다공증 예방 및 치료용 약학적 조성물
WO2016028899A1 (en) 2014-08-19 2016-02-25 The Coca-Cola Company Methods for preparing rebaudioside i and uses
US11230567B2 (en) 2014-09-02 2022-01-25 Purecircle Usa Inc. Stevia extracts enriched in rebaudioside D, E, N and/or O and process for the preparation thereof
CA2966487A1 (en) * 2014-11-06 2016-05-12 NWO Stem Cure, LLC Nutraceutical supplement with lactobacillus rhamnosus
AU2015353387B2 (en) 2014-11-29 2019-11-14 The Coca-Cola Company Novel diterpene glycosides, compositions and purification methods
KR101559937B1 (ko) * 2015-02-25 2015-10-14 주식회사 진용 홍화씨 추출물, 보스웰리아 추출물 및 황금 추출물을 유효성분으로 함유하는 뼈 길이 성장 촉진용 및 골밀도 증가용 식품 조성물
US20180289050A1 (en) 2015-05-20 2018-10-11 Cargill, Incorporated Glycoside compositions
RU2727426C2 (ru) 2015-08-27 2020-07-21 Пьюрсёркл Сдн Бхд Экстракты стевии
CN108289487A (zh) 2015-10-02 2018-07-17 可口可乐公司 具有改进的风味特征曲线的甜菊醇糖苷甜味剂
EP3436151A4 (en) 2016-03-28 2019-11-20 The Coca-Cola Company SWEET AND TASTE IMPROVEMENT OF STEVIOL GLYCOSIDE OR MOGROSIDE SUBSTANCES WITH FLAVONOIDS
US11751592B2 (en) 2016-04-06 2023-09-12 The Coca-Cola Company Sweetness and taste improvement of steviol glycoside or mogroside sweeteners
JP6706959B2 (ja) * 2016-04-07 2020-06-10 ポーラ化成工業株式会社 プロテオグリカン産生促進剤
KR101954696B1 (ko) * 2016-09-07 2019-03-07 연세대학교 산학협력단 층층나무속 추출물을 포함하는 골질환의 예방 또는 치료용 약학 조성물
US11447516B2 (en) 2016-10-04 2022-09-20 The Coca-Cola Company Diterpene glycosides containing an ent-atisene core, compositions and methods
CA3041123A1 (en) 2016-10-20 2018-04-26 The Coca-Cola Company Diterpene glycosides isolated from stevia, compositions and methods
JP7507460B2 (ja) * 2016-11-18 2024-06-28 株式会社東洋新薬 更年期症状の予防及び／又は改善組成物
CN117158570A (zh) 2016-12-01 2023-12-05 谱赛科美国股份有限公司 甜菊植物及其用途
US20200054058A1 (en) 2017-04-25 2020-02-20 The Coca-Cola Company Sweetness and Taste Improvement of Steviol Glycoside and Mogroside Sweeteners with Dihydrochalcones
CN110868870A (zh) 2017-05-12 2020-03-06 艾斯姆食品公司 大米产物及制备它们的系统和方法
CN111295101B (zh) 2017-06-27 2023-09-01 可口可乐公司 口服甜味剂组合物和方法
JP7391017B2 (ja) 2017-10-06 2023-12-04 カーギル インコーポレイテッド ステビオール配糖体溶解度エンハンサー
JP2019182863A (ja) * 2018-04-13 2019-10-24 養命酒製造株式会社 肌のハリ又はうるおいの改善用組成物
EP3787417B1 (en) 2018-04-30 2024-02-28 The Coca-Cola Company Methods for improving the solubility of steviol glycoside mixtures, and uses
EP3790410A4 (en) 2018-05-08 2022-03-30 EPC Natural Products Co., Ltd. SWEETENERS AND FLAVORING COMPOSITIONS, PROCESSES FOR THEIR PRODUCTION AND THEIR USE
KR102186886B1 (ko) * 2018-07-11 2020-12-04 한국 한의학 연구원 프루누스 자마사쿠라 추출물을 유효성분으로 함유하는 골다공증의 예방, 개선 또는 치료용 조성물
WO2020123067A2 (en) 2018-10-12 2020-06-18 Epc Natural Products Co., Ltd. Sweetener and flavor compositions, methods of making and methods of use thereof
KR20200064776A (ko) * 2018-11-29 2020-06-08 경희대학교 산학협력단 도인 추출물을 포함하는 골절 예방, 개선 또는 치료용 조성물
EP3952667A1 (en) 2019-04-06 2022-02-16 Cargill, Incorporated Sensory modifiers
AU2020353179A1 (en) 2019-09-27 2022-04-14 The Coca-Cola Company Sweetener blends with improved taste
KR102255000B1 (ko) * 2020-04-29 2021-05-24 한국 한의학 연구원 박하 추출물을 유효성분으로 함유하는 골질환의 예방, 개선 또는 치료용 조성물
KR102612089B1 (ko) * 2021-01-28 2023-12-14 대한민국 생강나무 잎 추출물의 유효성분을 포함하는 골다공증 예방 및 치료용 조성물
EP4395568A1 (en) 2021-09-01 2024-07-10 The Coca-Cola Company Methods and compositions comprising caffeine and/or a derivative thereof and a polyphenol
CN114886115A (zh) * 2022-04-18 2022-08-12 绵阳膳意生物科技有限公司 一种24节气均衡膳食组合物
WO2024081959A2 (en) 2022-10-14 2024-04-18 The Coca-Cola Company Methods and compositions for improving cognitive and mood functions

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556564A (en) * 1983-03-14 1985-12-03 Ethyl Corporation Feeding of zeolite A to poultry
FR2580929B1 (fr) * 1984-09-10 1988-10-07 Imbert Nicole Composition a base de plantes pour soulager et apaiser les douleurs de l'arthrose
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
IL86693A (en) * 1987-06-12 1994-06-24 Stichting Centraal Lab Proteins that have the activity IIIV of the blood, a process for their preparation that uses cells are produced through genetic engineering and pharmaceutical preparations that contain them
WO1991012792A1 (en) * 1990-03-02 1991-09-05 The Partnership Of Isaac G. Eliaz And Shmuel Gonen Method and product for promoting hair growth and treating skin conditions
US5162113A (en) * 1991-05-15 1992-11-10 Oh Jung M Oral composition for treating bone disorders
WO1995008318A2 (fr) * 1993-09-15 1995-03-30 Valentina Nikolaevna Peidus Substance medicinale a proprietes anti-infecteuses destinee a etre utilisee dans le traitement de la sterilite et dans la protection de la grossesse
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
JPH08119869A (ja) * 1994-10-26 1996-05-14 Mikimoto Pharmaceut Co Ltd 活性酸素抑制剤
JPH10511095A (ja) 1994-12-19 1998-10-27 ベス イスラエル ディーコネス メディカル センター インコーポレイテッド 副甲状腺ホルモン又はその作動薬の低用量継続投与
AU4607596A (en) 1994-12-20 1996-07-10 Osteosa Inc. Modulators of bone cell function and uses thereof
ZA95908B (en) * 1995-02-06 1995-10-13 Joshi Yeshwant Dr Kashinath A synergistic formulation for treatment of rheumatic diseases
JP3009599B2 (ja) * 1995-02-24 2000-02-14 フジッコ株式会社 フラボノイド配糖体を含む骨粗鬆症治療剤および骨粗鬆症治療用の可食性組成物
CN1055845C (zh) * 1995-06-05 2000-08-30 金纪前 跌打活血散
WO1997011095A1 (en) 1995-09-21 1997-03-27 The Trustees Of Columbia University In The City Of New York Uses of bone morphogenetic proteins
FR2740332B1 (fr) * 1995-10-26 1997-12-05 Oreal Composition pour la deformation permanente des fibres keratiniques, contenant un antagoniste de substance p ou un antagoniste de cgrp
JPH09187248A (ja) * 1995-11-06 1997-07-22 Nippon Oil & Fats Co Ltd 抗アレルギー食品
RU2102460C1 (ru) * 1996-05-13 1998-01-20 Уфимский винодельческий завод Композиция ингредиентов для бальзама "капова пещера"
CN1057218C (zh) * 1996-07-01 2000-10-11 谢景龙 一种用于治疗疮疡及外伤感染的中药制剂及其制备方法
JPH10130161A (ja) * 1996-09-06 1998-05-19 Otsuka Pharmaceut Co Ltd ヘリコバクター・ピロリに対する組成物
JPH10114653A (ja) * 1996-10-11 1998-05-06 Taishi Shokuhin Kogyo Kk 骨形成促進および骨塩量減少防止用組成物
CN1068189C (zh) * 1997-10-13 2001-07-11 刘国柱 玉米红薯果粥粉配方及制作工艺
JPH11130670A (ja) * 1997-10-27 1999-05-18 Oyo Seikagaku Kenkyusho 骨粗鬆症治療剤
US6235287B1 (en) * 1998-01-09 2001-05-22 Ida Development A/S Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments
DE19812204A1 (de) * 1998-03-19 1999-11-04 Plantamed Arzneimittel Gmbh Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung
US6123944A (en) * 1998-03-19 2000-09-26 Phytoceutica, Inc. Icariin preparations
DE19814725A1 (de) * 1998-04-02 1999-10-07 Michael O Ruepp Verwendung von Echinacea-pallida und Echinacea angustifolia-Extrakten; Löwenzahn-/Taraxacum)-Extrakten; Spitzwegerich-(Plantago)-Extrakten
WO1999055351A1 (en) * 1998-04-23 1999-11-04 Vladimir Leko Herbal composition and medicament against diabetes mellitus type ii manufactured thereof
US5908628A (en) * 1998-05-01 1999-06-01 Hou; Liping Compositions with analgesic, antipyretic and antiinflammatory properties
RU2138282C1 (ru) * 1998-05-14 1999-09-27 Суханов Александр Иванович Полиартритный сбор
JP3479224B2 (ja) * 1998-08-06 2003-12-15 森下仁丹株式会社 ハーブ植物を有効成分とする閉経後骨粗鬆症の予防又は治療剤
KR20000019869A (ko) * 1998-09-16 2000-04-15 정세영 홍화자 추출물을 포함하는 경조직 재생촉진제 조성물
GB9821670D0 (en) * 1998-10-05 1998-12-02 Muhlbauer Roman C Plant extracts for the treatment of increased bone resorption
JP2000191526A (ja) * 1998-12-25 2000-07-11 Marumiya:Kk 骨形成促進及び抗骨粗鬆症組成物
JP2000281567A (ja) * 1999-01-29 2000-10-10 Sunstar Inc スチルベン系化合物を含有する医薬及び食品組成物
JP3403350B2 (ja) * 1999-02-26 2003-05-06 ハウス食品株式会社 紅茶抽出物及びこれを含むゲル状食品
US20010024664A1 (en) * 1999-03-19 2001-09-27 Obukowicz Mark G. Selective COX-2 inhibition from edible plant extracts
AUPQ008399A0 (en) * 1999-04-28 1999-05-27 Novogen Research Pty Ltd Cariovascular applications
CN1084206C (zh) * 1999-05-20 2002-05-08 周金龙 一种治疗癌症的药物及其制备方法
AUPQ127399A0 (en) * 1999-06-29 1999-07-22 Guangzhou University Of Traditional Chinese Medicine Compositions and methods for treating or preventing osteoporosis
US6274176B1 (en) * 1999-07-01 2001-08-14 Chromak Research, Inc. Herbal compositions and their use as anti-inflammatory agents for alleviation of arthritis and gout
AUPQ138199A0 (en) 1999-07-02 1999-07-29 Telstra R & D Management Pty Ltd A search system
KR100814297B1 (ko) * 1999-07-09 2008-03-18 썬 팜 코포레이션 악성 종양 및 바이러스 감염을 치료하고 면역 기능을 향상시키기 위한 식이 보충제
GB2355189B (en) * 1999-08-20 2004-07-28 Yousef Haik Babikian Herbal preparation for the treatment of diabetes mellitus
JP2001064192A (ja) * 1999-08-25 2001-03-13 Sunstar Inc ランゲルハンス細胞の遊走抑制剤及び抗原提示抑制剤
US6242012B1 (en) * 1999-10-19 2001-06-05 Thomas Newmark Herbal composition for promoting hormonal balance in women and methods of using same
AU2446801A (en) * 1999-12-23 2001-07-03 Ancile Pharmaceuticals, Inc. Treatment for inflammatory bowel disease (ibd) and related conditions
CN1132598C (zh) * 2000-01-03 2003-12-31 谭翠玉 治疗骨质增生的益肾通痹丸及其制备方法
CN1122518C (zh) * 2000-01-07 2003-10-01 徐柏功 一种治疗妇科病的药物及其制备方法
CN1101202C (zh) * 2000-02-22 2003-02-12 陈永贵 一种复方骨质增生中药制剂
RU2162334C1 (ru) * 2000-04-24 2001-01-27 Титиева Наталья Михайловна Гомеопатическое лекарственное средство для лечения костно-суставной патологии (остеоартроз, остеохандроз, артрозы, артриты)
JP2001302539A (ja) * 2000-04-26 2001-10-31 Meiji Seika Kaisha Ltd 骨強化剤、骨強化用食品及び骨強化用飼料組成物
JP2001314173A (ja) * 2000-05-09 2001-11-13 Kyoto Eiyo Kagaku Kenkyusho:Kk 食品用組成物
JP2002003382A (ja) * 2000-06-20 2002-01-09 Nihon Shokken Co Ltd 関節軟骨再生促進及び軟骨減少防止用栄養補助組成物
WO2002013840A1 (en) * 2000-08-18 2002-02-21 University Of Bern Essential oils and chemically related species for the treatment of increased bone resorption
CN1120714C (zh) * 2000-09-27 2003-09-10 陈忠彦 一种治疗股骨头坏死的中药制剂及其制备方法
CN1163258C (zh) * 2000-12-27 2004-08-25 孔昭苓 一种药物组合物及制备方法
CN1136888C (zh) * 2001-05-09 2004-02-04 陈志友 治疗骨质增生及腰椎间盘脱出症的外用药物及其制备方法
EP1325681A1 (en) * 2001-12-11 2003-07-09 Société des Produits Nestlé S.A. Composition for promotion of bone growth and maintenance of bone health
CA2500527A1 (en) * 2002-10-01 2004-04-15 Takara Bio Inc. Remedies

Also Published As

Publication number Publication date
EP2135517A1 (en) 2009-12-23
AU2002366734A1 (en) 2003-07-09
HK1076009A1 (en) 2006-01-06
CN1602159A (zh) 2005-03-30
ES2387634T3 (es) 2012-09-27
CO5590866A2 (es) 2005-12-30
ES2387877T3 (es) 2012-10-03
EP2286675B1 (en) 2012-05-23
ES2387876T3 (es) 2012-10-03
JP5001342B2 (ja) 2012-08-15
DK1455601T4 (da) 2014-12-08
PT1455601E (pt) 2010-09-23
ZA200405454B (en) 2005-09-28
DK1455601T3 (da) 2010-09-27
WO2003053167A1 (en) 2003-07-03
MXPA04005583A (es) 2004-12-06
NO327135B1 (no) 2009-05-04
DK2286675T3 (da) 2012-08-20
AU2008201726A9 (en) 2008-05-15
DK2263480T3 (da) 2012-08-20
EP1455601B2 (en) 2014-11-19
BR0214838A (pt) 2004-08-31
AU2010201150A1 (en) 2010-04-15
IL161659A (en) 2008-07-08
KR20040083466A (ko) 2004-10-02
CA2469551C (en) 2016-11-08
DK2135517T3 (da) 2012-08-20
EP2272382A1 (en) 2011-01-12
US20090060883A1 (en) 2009-03-05
NO20042151L (no) 2004-09-07
US20050079232A1 (en) 2005-04-14
ES2347774T3 (es) 2010-11-04
CA2469551A1 (en) 2003-07-03
RU2314717C2 (ru) 2008-01-20
EP1325681A1 (en) 2003-07-09
PL369768A1 (en) 2005-05-02
EP2286675A1 (en) 2011-02-23
JP2010088441A (ja) 2010-04-22
CN100521972C (zh) 2009-08-05
EP2135517B1 (en) 2012-05-16
ATE472943T1 (de) 2010-07-15
PT2286675E (pt) 2012-08-14
EP2263480A1 (en) 2010-12-22
AU2010201150B2 (en) 2011-07-21
EP1455601A1 (en) 2004-09-15
AU2008201726A1 (en) 2008-05-08
JP4653951B2 (ja) 2011-03-16
UA84123C2 (ru) 2008-09-25
PT2135517E (pt) 2012-08-16
PT2263480E (pt) 2012-08-17
JP2010088442A (ja) 2010-04-22
JP2005513078A (ja) 2005-05-12
EP1455601B1 (en) 2010-07-07
DE60236961D1 (de) 2010-08-19
EP2263480B1 (en) 2012-05-23
AU2002366734B2 (en) 2008-12-11
IL161659A0 (en) 2004-09-27
AU2008201726B2 (en) 2010-08-12
RU2004121173A (ru) 2006-01-10

Similar Documents

Publication Publication Date Title
ES2347774T5 (es) Composición para la estimulación del crecimiento óseo y el mantenimiento de la salud ósea
NO20042150L (no) Naeringsmiddel- eller dyrefôrsammensetning som innheholder planteekstrakt for benhelsen
ECSP055739A (es) Anticuerpos de neutralización contra gdf-8, y sus usos
BRPI0416809A (pt) glicosamina
PL347469A1 (en) Use of certain drugs for treating nerve root injury
MY146809A (en) Treatment and prevention of osteoporosis
WO2001015715A3 (en) Composition for maintenance of bone or dental health or treatment of bone or dental disorders
WO2007113291A3 (en) Nutritional compositions for promotion of bone growth and maintenance of bone health and methods regarding same
DE60106026D1 (de) 2-arachidonylglycerol, ein hemmer des tumor nekrose faktors -alfa und neuroprotektor des gehirns bei geschlossenen kopfverletzungen
MX2010009314A (es) Polifenoles para el tratamiento de padecimientos de cartilago.
IL161700A0 (en) Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain
MY139463A (en) Food or pet food composition containing plant extract from amelanchier for bone health
ATE268599T1 (de) Verwendung von beta-naphtaquinon derivaten zur herstellung eines arzneimittels mit einem hemmenden effekt auf die glutamatfreisetzung durch das gehirn
PT1891960E (pt) Fórmula farmacêutica para o tratamento de doenças da pele
BR0307199A (pt) Derivados de drechsleranol, processo para a sua preparação e sua aplicação
BR0300548A (pt) Composição, medicamento, medicamento para a profilaxia ou terapia da pancreatite, suplemento alimentar, alimento de cuidado da saúde, ração, e, método para produzir a composição
UA70800C2 (ru) Способ оптимизации лечебного процесса
AR042682A1 (es) Metodo que mejora la circulacion sanguinea administrando una composicion que contiene un extracto acuoso de hojas de parra roja